Monopar Therapeutics Stock Hits 52-Week High at $38.91 By Investing.com
Monopar Therapeutics Inc . (NASDAQ: ) stock rose to a 52-week high at $38.91. The company, currently valued at $200 million, has analyst price targets of $37 to $72, according to InvestingPro. This milestone marks a significant period of growth for the company, which has seen its share price skyrocket over the past year. Investors … Read more